Cantero Therapeutics clinical trials
A subsidiary of BridgeBio
The registry lists 1 studies whose lead sponsor is Cantero Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 21, 2022.
Registry sponsor names on this page
- Cantero Therapeutics, a BridgeBio company1 study
Something wrong with this grouping? Tell us on the BridgeBio page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All BridgeBio studies →
- A Study of BBP-711 (ORF-229) in Healthy Adult VolunteersCompletedNCT04876924Phase 1
Sponsor listed in the registry: Cantero Therapeutics, a BridgeBio company